Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FVR FrontView REIT	$13.75 +3.4%	$12.21	$10.61 ▼ $19.76	$263.01M	N/A	202,866 shs	240,490 shs
INV Innventure	$4.42 +4.5%	$4.87	$3.00 ▼ $18.75	$236.41M	0.18	458,536 shs	91,377 shs
LOAN Manhattan Bridge Capital	$5.41 +0.5%	$5.44	$4.74 ▼ $6.05	$61.66M	0.34	19,517 shs	12,699 shs
OACC Oaktree Acquisition Corp. III Life Sciences	$10.41 +0.1%	$10.46	$9.95 ▼ $10.85	$233.44M	N/A	50,120 shs	53,874 shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FVR FrontView REIT	0.00%	+10.76%	+9.37%	+22.78%	+1,374,499,900.00%
INV Innventure	0.00%	+0.68%	-9.43%	-22.05%	+441,999,900.00%
LOAN Manhattan Bridge Capital	0.00%	+0.54%	-2.01%	+5.03%	+2.83%
OACC Oaktree Acquisition Corp. III Life Sciences	0.00%	+1.07%	-0.57%	+0.10%	+1,040,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FVR FrontView REIT	1.0158 of 5 stars	1.1	0.0	2.5	0.0	2.3	1.7	0.6
INV Innventure	2.7094 of 5 stars	3.8	0.0	0.0	0.0	1.8	2.5	0.6
LOAN Manhattan Bridge Capital	1.0942 of 5 stars	0.0	3.0	1.7	0.0	0.0	1.7	1.3
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FVR FrontView REIT	2.20	Hold	$15.10	9.86% Upside
INV Innventure	3.50	Strong Buy	$14.00	216.74% Upside
LOAN Manhattan Bridge Capital	0.00	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest LOAN, FVR, INV, and OACC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	FVR FrontView REIT	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$13.50
6/17/2025	FVR FrontView REIT	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Underperform	$15.00 ➝ $11.00
6/17/2025	FVR FrontView REIT	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$14.00 ➝ $12.00
6/10/2025	FVR FrontView REIT	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$15.00 ➝ $14.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FVR FrontView REIT	$66.68M	3.94	$0.50 per share	27.37	$26.40 per share	0.52
INV Innventure	$1.22M	193.79	N/A	N/A	$7.97 per share	0.55
LOAN Manhattan Bridge Capital	$9.69M	6.39	$0.50 per share	10.85	$3.80 per share	1.42
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FVR FrontView REIT	-$22.21M	-$1.07	N/A	11.55	N/A	-43.21%	-5.48%	-3.33%	11/12/2025 (Estimated)
INV Innventure	-$78.19M	N/A	0.00	N/A	N/A	-20,429.67%	-33.64%	-25.35%	N/A
LOAN Manhattan Bridge Capital	$5.59M	$0.47	11.51	∞	N/A	59.04%	12.68%	8.07%	10/21/2025 (Estimated)
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest LOAN, FVR, INV, and OACC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	INV Innventure	-$0.17	-$1.60	-$1.43	-$1.60	$0.69 million	$0.48 million
7/22/2025	Q2 2025	LOAN Manhattan Bridge Capital	$0.12	$0.12	N/A	$0.12	N/A	$2.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FVR FrontView REIT	$0.86	6.26%	N/A	N/A	N/A
INV Innventure	N/A	N/A	N/A	N/A	N/A
LOAN Manhattan Bridge Capital	$0.46	8.50%	N/A	97.87%	1 Years
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A

Latest LOAN, FVR, INV, and OACC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/14/2025	FVR FrontView REIT	quarterly	$0.2150	6.9%	9/30/2025	9/30/2025	10/15/2025
7/28/2025	LOAN Manhattan Bridge Capital	quarterly	$0.1150	8.47%	10/8/2025	10/8/2025	10/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FVR FrontView REIT	0.63	0.73	0.17
INV Innventure	0.04	0.29	0.11
LOAN Manhattan Bridge Capital	N/A	2.79	2.79
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FVR FrontView REIT	N/A
INV Innventure	55.98%
LOAN Manhattan Bridge Capital	21.84%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Insider Ownership

Company	Insider Ownership
FVR FrontView REIT	4.30%
INV Innventure	23.13%
LOAN Manhattan Bridge Capital	24.50%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FVR FrontView REIT	N/A	19.09 million	18.27 million	N/A
INV Innventure	N/A	53.49 million	41.12 million	N/A
LOAN Manhattan Bridge Capital	6	11.44 million	8.64 million	Optionable
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	22.43 million	N/A	N/A

LOAN, FVR, INV, and OACC Headlines

Recent News About These Companies

Kepos Capital LP Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 15, 2025 | marketbeat.com

Mizuho Securities USA LLC Purchases New Holdings in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 13, 2025 | marketbeat.com

Picton Mahoney Asset Management Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 1, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LOAN, FVR, INV, and OACC Company Descriptions

FrontView REIT NYSE:FVR

$13.74 +0.46 (+3.42%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$13.78 +0.03 (+0.22%)

As of 08/22/2025 04:10 PM Eastern

FrontView REIT specializes in real estate investing.

Innventure NASDAQ:INV

$4.42 +0.19 (+4.49%)

As of 08/22/2025 04:00 PM Eastern

Innventure Inc. founds, funds and operates companies with a focus on transformative, sustainable technology solutions acquired or licensed from multinational corporations. Innventure Inc., formerly known as Learn CW Investment Corporation, is based in ORLANDO, Fla.

Manhattan Bridge Capital NASDAQ:LOAN

$5.41 +0.03 (+0.54%)

Closing price 08/22/2025 03:58 PM Eastern

Extended Trading

$5.40 -0.01 (-0.26%)

As of 08/22/2025 07:04 PM Eastern

Manhattan Bridge Capital, Inc., a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. The company offers short-term, secured, and non-banking loans to real estate investors to fund acquisition, renovation, rehabilitation, or development of residential or commercial properties. Its loans are secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 1989 and is headquartered in Great Neck, New York.

Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC

$10.41 +0.01 (+0.10%)

As of 08/22/2025 03:33 PM Eastern

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time